Suzhou MedicalSystem Technology Co., Ltd.
SSE:603990.SS
15.83 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 464.069 | 618.141 | 305.507 | 353.847 | 308.079 | 333.116 | 284.277 | 268.68 | 240.643 | 201.871 | 180.471 | 142.793 | 101.327 | 62.274 |
| Cost of Revenue
| 400.717 | 499.937 | 90.051 | 106.859 | 85.367 | 93.031 | 72.59 | 70.615 | 75.006 | 61.094 | 61.822 | 42.93 | 31.17 | 18.049 |
| Gross Profit
| 63.352 | 118.204 | 215.456 | 246.987 | 222.712 | 240.085 | 211.686 | 198.065 | 165.637 | 140.777 | 118.649 | 99.863 | 70.157 | 44.225 |
| Gross Profit Ratio
| 0.137 | 0.191 | 0.705 | 0.698 | 0.723 | 0.721 | 0.745 | 0.737 | 0.688 | 0.697 | 0.657 | 0.699 | 0.692 | 0.71 |
| Reseach & Development Expenses
| 51.179 | 50.04 | 47.41 | 48.005 | 43.032 | 57.687 | 57.248 | 47.83 | 35.228 | 20.056 | 14.474 | 10.564 | 9.466 | 0 |
| General & Administrative Expenses
| 31.617 | 54.768 | 19.027 | 24.448 | 15.135 | 13.952 | 11.039 | 12.016 | 11.603 | 11.9 | 13.659 | 11.945 | 30.485 | 22.832 |
| Selling & Marketing Expenses
| 28.265 | 80.183 | 61.548 | 79.381 | 76.624 | 73.695 | 64.598 | 62.556 | 61.575 | 55.106 | 53.22 | 42.226 | 31.011 | 22.048 |
| SG&A
| 59.881 | 293.271 | 80.574 | 103.829 | 91.759 | 87.647 | 75.637 | 74.572 | 73.178 | 67.006 | 66.878 | 54.17 | 61.496 | 44.88 |
| Other Expenses
| 205.55 | 36.841 | 28.459 | 27.066 | 10.554 | 10.725 | -0.036 | 2.631 | 27.364 | 18.876 | 26.428 | 18.051 | 12.815 | 6.113 |
| Operating Expenses
| 316.61 | 380.152 | 156.443 | 178.9 | 145.345 | 156.059 | 136.815 | 136.116 | 135.439 | 108.24 | 98.074 | 78.507 | 63.863 | 46.123 |
| Operating Income
| -253.257 | -261.948 | 68.465 | 76.574 | 75.581 | 74.775 | 60.474 | 52.886 | 24.112 | 26.877 | 18.554 | 17.843 | 3.752 | -3.784 |
| Operating Income Ratio
| -0.546 | -0.424 | 0.224 | 0.216 | 0.245 | 0.224 | 0.213 | 0.197 | 0.1 | 0.133 | 0.103 | 0.125 | 0.037 | -0.061 |
| Total Other Income Expenses Net
| -0.477 | -0.042 | -0.502 | -25.238 | -0.146 | 8.865 | -0.036 | 2.631 | 25.119 | 18.67 | 26.36 | 18.049 | 12.812 | 6.041 |
| Income Before Tax
| -253.734 | -261.99 | 43.556 | 51.336 | 48.573 | 53.923 | 60.437 | 55.517 | 49.23 | 45.547 | 44.913 | 35.892 | 16.564 | 2.257 |
| Income Before Tax Ratio
| -0.547 | -0.424 | 0.143 | 0.145 | 0.158 | 0.162 | 0.213 | 0.207 | 0.205 | 0.226 | 0.249 | 0.251 | 0.163 | 0.036 |
| Income Tax Expense
| 23.865 | 3.253 | 8.067 | 7.832 | 6.607 | 6.807 | 5.375 | 4.406 | 4.025 | 6.591 | 5.667 | 4.807 | 2.563 | 0.646 |
| Net Income
| -279.475 | -269.419 | 33.561 | 41.953 | 35.443 | 46.887 | 55.48 | 51.111 | 45.206 | 38.956 | 39.246 | 31.085 | 14 | 1.61 |
| Net Income Ratio
| -0.602 | -0.436 | 0.11 | 0.119 | 0.115 | 0.141 | 0.195 | 0.19 | 0.188 | 0.193 | 0.217 | 0.218 | 0.138 | 0.026 |
| EPS
| -0.92 | -0.88 | 0.12 | 0.15 | 0.14 | 0.19 | 0.23 | 0.21 | 0.24 | 0.21 | 0.21 | 0.17 | 0.075 | 0.052 |
| EPS Diluted
| -0.92 | -0.88 | 0.12 | 0.15 | 0.14 | 0.19 | 0.22 | 0.21 | 0.24 | 0.21 | 0.21 | 0.17 | 0.075 | 0.052 |
| EBITDA
| -102.445 | -179.968 | 67.065 | 76.565 | 69.808 | 82.381 | 76.225 | 69.244 | 32.07 | 47.296 | 48.548 | 39.179 | 10.269 | -0.341 |
| EBITDA Ratio
| -0.221 | -0.291 | 0.22 | 0.216 | 0.227 | 0.247 | 0.268 | 0.258 | 0.133 | 0.234 | 0.269 | 0.274 | 0.101 | -0.005 |